MERRIMACK PHARMACEUTICALS INC

CAMBRIDGE, MA How do I update this listing?

Create Email Alert

Merrimack Pharmaceuticals is based out of Cambridge. Merrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. Merrimack applies Network Biology, its proprietary systems biology-based approach to biomedical research, throughout the research and development process. Merrimack currently has five targeted therapeutic oncology candidates in clinical development.Whalewisdom has at least 180 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2011-04-13. The notice included securities offered of Equity

Contact Info

merrimack pharmaceuticals inc
ONE BROADWAY
CAMBRIDGE MA    02142

Business Phone: 617-441-1000
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2011-04-13 D PHARMACEUTICALS Equity 77,000,000 77,000,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ROBERT J. MULROY subscription required
    EXECUTIVE OFFICER DIRECTOR
WILLIAM A. SULLIVAN subscription required
    EXECUTIVE OFFICER
GARY CROCKER subscription required
    DIRECTOR
JAMES DRESSER subscription required
    DIRECTOR
GORDON FEHR subscription required
    DIRECTOR
ROBERT GAY subscription required
    DIRECTOR
WALTER LOVENBERG subscription required
    DIRECTOR
SARAH NASH subscription required
    DIRECTOR
MICHAEL PORTER subscription required
    DIRECTOR
ANTHONY SINSKEY subscription required
    DIRECTOR

Elevate your investments